Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (DGX) — Form 144: Proposed sale of shares
AI-generated summary
Director Gary M. Pfeiffer of Quest Diagnostics Incorporated proposed to sell 1,203 common shares with an aggregate market value of $292,329 through Fidelity Brokerage Services LLC. The shares were originally acquired through a restricted stock vesting on May 15, 2026. The proposed sale is scheduled for October 26, 2026.
Key facts
- Seller
- PFEIFFER GARY M
- Relationship
- Director
- Shares to sell
- 1,203
- Market value
- $292,329.00
- Approximate sale date
- Oct 26, 2026
- Broker
- Fidelity Brokerage Services LLC
- Acquired
- May 15, 2026 · Restricted Stock Vesting
Rule 10b5-1 plan · adopted May 29, 2026
More DGX filings
- 4
Filed Oct 28, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.